What is NDC 59762-1389?

59762-1389 is the product NDC for Doxazosin mesylate, Doxazosin mesylate 2 mg/1 tablet, listed with the FDA by Mylan Pharmaceuticals Inc..

Mylan Pharmaceuticals Inc., NDC labeler code 59762. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Doxazosin mesylate?

13 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Doxazosin mesylate NDC 59762-1389 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59762-1389Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59762-1389Add the package segment from the table below.

Product information

Brand name (proprietary): Doxazosin mesylate
Generic name (nonproprietary): doxazosin mesylate
Active ingredients: Doxazosin mesylate — 2 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Mylan Pharmaceuticals Inc.NDC labeler code 59762
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 019668
Marketing start: May 9, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 59762-1389_fcdd575b-bb02-49a4-bd2c-a7e339be0878SPL ID fcdd575b-bb02-49a4-bd2c-a7e339be0878SPL set ID 2e524986-7903-416f-b2b8-d27295103e75RxCUI 197625, 197626, 197627, 197628UNII 86P6PQK0MUUPC 0359762138972, 0359762139078, 0359762138873, 0359762139177
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match: No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

Product label

Current FDA label (SPL), effective Mar 11, 2024.

Indications (excerpt from the label)

Doxazosin is an alpha 1 adrenergic antagonist indicated for: • Signs and symptoms of Benign Prostatic Hyperplasia (BPH) ( 1.1 ) • Treatment of Hypertension ( 1.2 ) 1.1 Benign Prostatic Hyperplasia (BPH) Doxazosin tablet is indicated for the treatment of the signs and symptoms of BPH. 1.2 Hypertension Doxazosin tablet is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure s…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59762-1389

What is NDC 59762-1389?: 59762-1389 is the product NDC for Doxazosin mesylate, Doxazosin mesylate 2 mg/1 tablet, listed with the FDA by Mylan Pharmaceuticals Inc..
What drug is associated with this NDC?: Doxazosin mesylate.
What is the active ingredient?: Doxazosin mesylate.
Who is the labeler?: Mylan Pharmaceuticals Inc., NDC labeler code 59762. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Doxazosin mesylate?: 13 other product NDCs are listed under this name. See all Doxazosin mesylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Doxazosin mesylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Doxazosin mesylate	Doxazosin mesylate 8 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-1391	59762-1391-07
Doxazosin mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-1390	59762-1390-07
Doxazosin mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-965	71610-0965-5371610-0965-6071610-0965-70
Doxazosin mesylate	Doxazosin mesylate 1 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-1388	59762-1388-07
Doxazosin Mesylate	Doxazosin mesylate 1 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-351	29300-0351-0129300-0351-1029300-0351-13
Doxazosin Mesylate	Doxazosin mesylate 2 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-352	29300-0352-0129300-0352-1029300-0352-13
Doxazosin Mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-353	29300-0353-0129300-0353-1029300-0353-13
Doxazosin Mesylate	Doxazosin mesylate 8 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-354	29300-0354-0129300-0354-1029300-0354-13
Doxazosin Mesylate	Doxazosin mesylate 2 mg/1	TabletOral	Unichem Laboratories Limited, India	53747-352	53747-0352-0153747-0352-1053747-0352-13
Doxazosin mesylate	Doxazosin mesylate 1 mg/1	TabletOral	Chartwell RX, LLC	62135-051	62135-0051-90

All 14 Doxazosin mesylate NDCs

Other NDCs under NDA 019668

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 019668
Product	Strength	Form · route	Labeler	Product NDC
Carduradoxazosin	Doxazosin mesylate 8 mg/1	TabletOral	ROERIG	0049-2716
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-927
Carduradoxazosin	Doxazosin mesylate 2 mg/1	TabletOral	ROERIG	0049-2512
Doxazosin mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-965
Carduradoxazosin	Doxazosin mesylate 4 mg/1	TabletOral	ROERIG	0049-2614
Doxazosin mesylate	Doxazosin mesylate 4 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-1390
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-628
Doxazosin mesylate	Doxazosin mesylate 1 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-1388
Doxazosin mesylate	Doxazosin mesylate 8 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-1391
Carduradoxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Viatris Specialty LLC	58151-075
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-2420
Carduradoxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Viatris Specialty LLC	58151-074
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-2440
Carduradoxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Viatris Specialty LLC	58151-076
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-2480
Carduradoxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Viatris Specialty LLC	58151-077